LDR | |
012836am a2200313 a 4500 |
001 |
|
008570472 |
003 |
|
MiAaHDL |
005 |
|
20100720000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
880202s1987 enka b 00010 eng d |
020 |
⊔ |
⊔ |
‡a9179003060
|
035 |
⊔ |
⊔ |
‡asdr-inu2102608
|
035 |
⊔ |
⊔ |
‡a(OCoLC)17422138
|
040 |
⊔ |
⊔ |
‡aTXA
‡cTXA
‡dKKP
‡dAGL
‡dIUL
|
090 |
⊔ |
⊔ |
‡aQP1
‡b.A2 Suppl., no.565
‡mIULE
|
100 |
1 |
0 |
‡aHärfstrand, Anders.
|
245 |
1 |
0 |
‡aBrain neuropeptide Y mechanisms :
‡bbasic aspects and involvement in cardiovascular and neuroendocrine regulation /
‡cby Anders Härfstrand.
|
260 |
0 |
⊔ |
‡aOxford [England] ;
‡aBoston :
‡bPublished for the Scandinavian Physiological Society by Blackwell Scientific Publications,
‡c1987.
|
300 |
⊔ |
⊔ |
‡a83 p. :
‡bill. ; 25 cm.
|
490 |
0 |
⊔ |
‡aActa physiologica Scandinavica, Supplementum ;
‡x0302-2994.
‡v565
|
504 |
⊔ |
⊔ |
‡aBibliography: p. 52-83.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aCardiovascular System
‡xdrug effects.
|
650 |
⊔ |
2 |
‡aNeurosecretory Systems
‡xphysiology.
|
650 |
⊔ |
2 |
‡aNeuropeptide Y
‡xphysiology.
|
650 |
⊔ |
0 |
‡aCardiovascular agents.
|
650 |
⊔ |
0 |
‡aNeuroendocrinology.
|
650 |
⊔ |
0 |
‡aHeart
‡xEffect of drugs on.
|
650 |
⊔ |
0 |
‡aNeuropeptides.
|
710 |
2 |
0 |
‡aScandinavian Society for Physiology.
|
CID |
⊔ |
⊔ |
‡a008570472
|
DAT |
0 |
⊔ |
‡a20100720111512.0
‡b20100720000000.0
|
DAT |
1 |
⊔ |
‡a20120814113535.0
‡b2024-01-08T18:55:44Z
|
CAT |
⊔ |
⊔ |
‡aSDR-INU
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-inu2102608
‡ainu
‡bSDR
‡cINU
‡pinu.30000120398056
‡sINU
‡zSuppl. no.565
‡12102608
|
974 |
⊔ |
⊔ |
‡bINU
‡cINU
‡d20240108
‡sgoogle
‡uinu.30000120398056
‡zSuppl. no.565
‡y1987
‡ric
‡qbib
‡tnon-US bib date1 >= 1930
|